The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

Trial Profile

The Use of Recombinant hCG to Prevent Breast Cancer in BRCA1 and BRCA2 Carriers

Recruiting
Phase of Trial: Phase IV

Latest Information Update: 16 Apr 2018

At a glance

  • Drugs Choriogonadotropin alfa (Primary)
  • Indications Breast cancer
  • Focus Pharmacodynamics; Pharmacogenomic; Proof of concept
  • Most Recent Events

    • 16 Apr 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top